Static Implant Versus Dynamic Implant in the Surgical Treatment on Ankle Syndesmosis Rupture
Prospective Randomized Multicentric Trial Comparing a Static Implant and a Dynamic Implant in the Surgical Treatment of Ankle Syndesmosis Rupture
1 other identifier
interventional
70
1 country
1
Brief Summary
Ankle fracture is frequent and its number is increasing. In Canada, surgical treatment of these lesions is advised and the options currently used all have in common a rigid fixation of the syndesmosis which results in residual stiffness and a high level of secondary surgery, mostly to remove the implant. The purpose of the study is to compare the treatment of ankle syndesmotic rupture by a dynamic fixation to a static fixation suggesting that the dynamic fixation method will improve the Olerud-Molander functional score of more than 15 points at the 3 months follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2008
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
April 21, 2010
CompletedFirst Posted
Study publicly available on registry
April 23, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedDecember 20, 2012
December 1, 2012
2.3 years
April 21, 2010
December 19, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Olerud-Molander score
The Olerud-Molander scoring scale was chosen because it adequately represents the ankle performance following surgery (trauma or elective basis). It comprises nine functional parameters which are concerned with primary complaints, the ability to perform simple tasks and the everyday life activities.
3 months after surgery
Secondary Outcomes (23)
Rate of secondary surgery
within one year following surgery
Radiological loss of reduction
2 weeks after surgery
Implant failure
one year after surgery
Radiological loss of reduction
6 weeks after surgery
Radiological loss of reduction
12 weeks after surgery
- +18 more secondary outcomes
Study Arms (2)
TightRope System
ACTIVE COMPARATORPatients are operated on using the TightRope implant by Arthrex.
Screw fixation implant
ACTIVE COMPARATORPatients are operated on using the rigid four-cortices 3,5 mm screw fixation by Synthes.
Interventions
Patients are operated on using a dynamic implant, the TightRope System by Arthrex®. The ankle is immobilized in a plaster boot for 6 weeks.
Patients are operated on using a static implant, the rigid four-cortices 3,5 mm screw fixation by Synthes®. The ankle is immobilized in a plaster boot for 6 weeks.
Eligibility Criteria
You may qualify if:
- men or women ≥ 18 years-old;
- ankle fracture type 44-C (AO classification) with an AP, lateral and mortise X-ray views of the ankle and an AP and lateral X-ray views of the leg;
- open fractures (Gustilo I-IIIb) or closed;
- trauma-surgery delay of less than 7 days;
- consent form signed.
You may not qualify if:
- ankle fractures without syndesmotic lesion;
- fracture associated with neuro-vascular lesions (Gustillo IIIc);
- pathologic fracture;
- fracture in a polytraumatized patient;
- fracture of a bone in the ipsilateral leg;
- men or women \> 65 years-old;
- chronic cardiac insufficiency (ejection fraction \< 30%);
- lower leg chronic venous insufficiency;
- neuro-arthropathic foot (Charcot, diabetes, etc…);
- body mass index ≥ 40;
- past medical history of fracture of the same ankle;
- medical conditions too serious for a surgery;
- men or women unfit to consent;
- any other conditions that make the examinator thinks that the follow up would be problematic.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hopital de l'Enfant-Jesuslead
- Arthrex, Inc.collaborator
Study Sites (1)
CHA-Pavillon Enfant-Jésus
Québec, Quebec, G1J 1Z4, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Stéphane Pelet, MD, PhD
Hôpital Enfant-Jésus
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr Stephane Pelet MD, PhD Orthopedic surgeon
Study Record Dates
First Submitted
April 21, 2010
First Posted
April 23, 2010
Study Start
October 1, 2008
Primary Completion
February 1, 2011
Study Completion
January 1, 2012
Last Updated
December 20, 2012
Record last verified: 2012-12